These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 2868149

  • 21. Evaluation of TSH-receptor antibodies as prognostic markers after cessation of antithyroid drug treatment in patients with Graves' disease.
    Kasagi K, Iida Y, Hatabu H, Tokuda Y, Arai K, Endo K, Konishi J.
    Acta Endocrinol (Copenh); 1988 Feb; 117(2):173-80. PubMed ID: 2454576
    [Abstract] [Full Text] [Related]

  • 22. Failure of anti-TSH receptor antibodies (TRAb) to predict the outcome of the course of Graves' disease following withdrawal of antithyroid drug.
    Shoda Y, Akiyama H, Yamaguchi T, Inukai T, Kobayashi I, Kondo Y, Kobayashi S.
    Exp Clin Endocrinol; 1991 Mar; 97(1):113-6. PubMed ID: 1677893
    [Abstract] [Full Text] [Related]

  • 23. [Clinical studies on abnormal thyroid stimulators in patients with Graves' disease. I. A sensitive assay for thyroid-stimulating antibodies using cultured porcine thyroid cells and polyethylene glycol precipitation of serum].
    Uno C, Nishikawa M.
    Nihon Naibunpi Gakkai Zasshi; 1988 Mar 20; 64(3):193-205. PubMed ID: 2899523
    [Abstract] [Full Text] [Related]

  • 24. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS, Zwicker H, Abbott EC, Douglas R, Givner ML, Gupta MK, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE.
    J Clin Endocrinol Metab; 1996 Sep 20; 81(9):3283-8. PubMed ID: 8784084
    [Abstract] [Full Text] [Related]

  • 25. Immunological findings and thyroid function of untreated Graves' disease patients with undetectable TSH-binding inhibitor immunoglobulin.
    Mukuta T, Tamai H, Oshima A, Morita T, Matsubayashi S, Fukata S, Kuma K.
    Clin Endocrinol (Oxf); 1994 Feb 20; 40(2):215-9. PubMed ID: 7907955
    [Abstract] [Full Text] [Related]

  • 26. Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease.
    Shibayama K, Ohyama Y, Yokota Y, Ohtsu S, Takubo N, Matsuura N.
    Endocr J; 2005 Oct 20; 52(5):505-10. PubMed ID: 16284425
    [Abstract] [Full Text] [Related]

  • 27. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK, Plicht M, Lax H, Hirche H, Quadbeck B, Mann K, Steuhl KP, Esser J, Morgenthaler NG.
    Clin Endocrinol (Oxf); 2004 Nov 20; 61(5):612-8. PubMed ID: 15521965
    [Abstract] [Full Text] [Related]

  • 28. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.
    Mori Y, Matoba N, Miura S, Sakai N, Taira Y.
    World J Surg; 1992 Nov 20; 16(4):647-52; discussion 652-3. PubMed ID: 1357830
    [Abstract] [Full Text] [Related]

  • 29. Relationship among thyrotropin (TSH), thyroid stimulating immunoglobulins, and results of triiodothyronine (T3) suppression test in patients with Graves' disease.
    Horimoto M, Nishikawa M, Uno C, Yoshikawa N, Taniguchi N, Inada M.
    Endocrinol Jpn; 1988 Dec 20; 35(6):841-8. PubMed ID: 2471633
    [Abstract] [Full Text] [Related]

  • 30. The assay of Graves' immunoglobulins: a comparison of different methods.
    Hardisty CA, Kendall-Taylor P, Atkinson S, Humphries H, Munro DS.
    Clin Endocrinol (Oxf); 1983 Jun 20; 18(6):637-44. PubMed ID: 6136348
    [Abstract] [Full Text] [Related]

  • 31. Clinical experience with a radioreceptor assay for TSH-binding inhibiting immunoglobulins (TBII).
    Heberling HJ, Bierwolf B, Lohmann D.
    Exp Clin Endocrinol; 1988 Aug 20; 91(3):355-61. PubMed ID: 2908034
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease.
    Cho BY, Shong MH, Yi KH, Lee HK, Koh CS, Min HK.
    Clin Endocrinol (Oxf); 1992 Jun 20; 36(6):585-90. PubMed ID: 1358483
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Thyrotrophin binding inhibiting immunoglobulins in Graves' disease before, during and after antithyroid therapy, and its relation to long-acting thyroid stimulator.
    Docter R, Bos G, Visser TJ, Hennemann G.
    Clin Endocrinol (Oxf); 1980 Feb 20; 12(2):143-53. PubMed ID: 6105023
    [Abstract] [Full Text] [Related]

  • 37. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
    Takasu N, Kamijo K, Sato Y, Yoshimura H, Nagata A, Ochi Y.
    Clin Exp Pharmacol Physiol; 2004 Feb 20; 31(5-6):314-9. PubMed ID: 15191404
    [Abstract] [Full Text] [Related]

  • 38. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ, Lee BW, Kim JY, Jung JH, Min YK, Lee MS, Lee MK, Kim KW, Chung JH.
    Thyroid; 2006 Dec 20; 16(12):1251-7. PubMed ID: 17199435
    [Abstract] [Full Text] [Related]

  • 39. Onset of subacute aggravation of chronic thyroiditis followed immediately by transient hypothyroidism during antithyroid drug therapy for Graves' hyperthyroidism.
    Shigemasa C, Shirota K, Urabe K, Kouchi T, Mitani Y, Ueta Y, Yoshida A, Mashiba H.
    Horm Res; 1991 Dec 20; 35(5):208-12. PubMed ID: 1687041
    [Abstract] [Full Text] [Related]

  • 40. Long-term effects of radioiodine on thyrotrophin receptor antibodies in Graves' disease.
    Aizawa Y, Yoshida K, Kaise N, Kaise K, Fukazawa H, Kiso Y, Mori K, Sayama N, Kikuchi K, Abe K.
    Clin Endocrinol (Oxf); 1995 May 20; 42(5):517-22. PubMed ID: 7621571
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.